Transition in Sickle Cell Disease (SCD): A German Consensus Recommendation.

Area of Science:

• Hematology
• Public Health
• Healthcare Management

Background:

• Sickle cell disease (SCD) is increasingly prevalent in Germany, leading to significant acute and chronic morbidities.
• A rising mortality rate in young adults with SCD necessitates improved care structures.
• Existing healthcare systems face challenges in managing chronic diseases, particularly during patient transitions.

Purpose of the Study:

• To establish the first multicenter German consensus statement on transitioning SCD patients.
• To advocate for a standardized guideline for safe transition from pediatric to adult care.
• To address the need for early identification and intervention for medical needs in chronic diseases.

Main Methods:

• Development of a consensus statement based on multicenter expert input.
• Review of current transition practices and challenges for SCD patients in Germany.
• Analysis of healthcare needs and economic implications.

Main Results:

• A critical need for a standardized transition guideline for adolescents and young adults with SCD in Germany.
• Identification of structural barriers hindering effective healthcare transitions.
• Emphasis on the importance of integrating transition services into regular care for chronically ill youth.

Conclusions:

• Implementing a standardized transition guideline is essential for improving SCD patient outcomes in Germany.
• Addressing structural barriers and ensuring cost coverage are key to successful transition processes.
• Early intervention and structured care can reduce disease burden and economic impact.